Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    13-AT-0143
Show Display Options
Rank Status Study
1 Recruiting Brain Response to Pain Control in People With Chronic Pain
Condition: Pain
Intervention:
2 Recruiting Piogliatazone for Alcohol Craving
Conditions: Alcohol Dependence;   Alcohol Drinking;   Stress;   Alcohol-Related Disorders
Interventions: Drug: Pioglitazone;   Drug: Placebo
3 Active, not recruiting Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate/vilanterol;   Drug: fluticasone furoate;   Drug: vilanterol;   Other: Placebo
4 Completed EW-A-401 to Treat Intermittent Claudication
Conditions: Intermittent Claudication;   Arteriosclerosis
Interventions: Drug: DNA Plasmid Vector;   Drug: EW-A-401 DNA Plasmid Vector
5 Recruiting Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease;   Prodromal Alzheimer's Disease
Interventions: Drug: MK-8931;   Drug: Placebo
6 Recruiting B0151005 Open-Label Extension Study
Condition: Crohn's Disease
Intervention: Biological: PF-04236921
7 Unknown  Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia
Condition: B-Chronic Lymphocytic Leukemia
Interventions: Drug: Pentostatin;   Drug: Rituximab;   Drug: Cyclophosphamide
8 Recruiting An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
Condition: Stage IV or Recurrent Non-Small Cell Lung Cancer
Interventions: Biological: Nivolumab;   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pemetrexed
9 Recruiting Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: BMS-188667;   Drug: Mycophenolate mofetil;   Drug: Prednisone;   Biological: Placebo matching with BMS-188667

Indicates status has not been verified in more than two years